Page 1

How to Register To attend EDEC 2012 all participants must register online or fax the manual registration form to the Congress Secretariat. Registration confirmation will only be acknowledged once the registration fee has been received. Each delegate must complete a separate registration from. For registration please visit:

Registration Fee Registration Fee


(1/9/2012 to 4/10/2012)

Physicians Residents, Nurses, Medical Students & Interns

Who Should Attend This continuing medical education activity should be of substantial interest to: Endocrinologists

General practitioners

Pediatric Endocrinologists

Family physicians

Internal medicine



Diabetes educators and dietician


Clinical researchers


Other Healthcare professionals



US$ 375 US$ 275

Located in the Bur Dubai district, Grand Hyatt Dubai hotel towers majestically over the edge of Dubai's historic creek. The hotel is close to financial and entertainment districts, the Dubai Creek, Dubai WTC and Wafi City Shopping Mall, while Dubai International Airport is only 7 km away. Set within 37 acres of landscaped gardens, o ur Dubai hotel is an outstanding combination of resort facilities, luxury hotel rooms & suites, residential apartments and one of the most advanced conference and business hotels in the United Arab Emirates and Middle East. Our 5 star hotel in Dubai hosts a wide array of restaurants, bars and cafÊs, most of them located around the tropical garden of the atrium. Grand Hyatt Dubai, a perfect blend of city conference and resort hotel, is set within a lush oasis of 37 acres of landscaped gardens. Towering over Dubai Creek, the hotel is minutes away from Dubai’s shopping, entertainment and business districts and within easy access of the international airport.

CME Certification This Congress is accredited for 14 CME hrs by Dubai Health Authority (DHA) & awaiting CME hrs from UAE University

11th - 13th October, 2012 Grand Hyatt Conference & Convention Centre, Dubai, United Arab Emirates

On Site Fee US$ 400 US$ 300

Please note that the online / pre registration will be closed from 4th October 2012 onwards. All registrations and name changes received after the 4th October will be processed on site with the applicable onsite registration fee. There will be an opportunity to register on site at the Grand Hyatt Dubai.

Sponsorship/ Exhibition Opportunities Wide range of sponsorship opportunities are available at the EDEC 2012, to maximize your brand coverage. Also available is an exhibition area diplaying pharmaceutical products, diagnostics and lab tests, lab ware, medical equipment, and instruments. For more information please contact the Congress Secretariat at:

Grand Hyatt Dubai


14 CME Hr Accredi s ted by DHA

In Support with

Organised by

Congress Secretariat

Main Sponsor

For further information on registration, exhibition and sponsorship please contact congress secretariat:

Platinum Sponsors

Gold Sponsors

MCI Dubai PO Box 124752 Dubai, United Arab Emirates Tel: +971 4 311 6300 Fax: +971 4 311 6301 Email:

Silver Sponsors

Support Sponsors

Bronze Sponsors

Official News Distributor

Media Partners

Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail:

Welcome Message

*Scientific Program

*Scientific Program

Dear Participants,

Pre Congress Ultrasound Workshop

AhlanWahSalan! Marhaba! And Welcome back! Last year, this time, we were all busy gearing up for the World Diabetes Congress in Dubai. It was the first Congress of the International Diabetes Federation (IDF) in the Middle East and North Africa region. As hosts, we had great expectations with regards to the outcome of the Scientific Content, Participation and the impact the congress would have in the Region. We can proudly state that our team and the congressover delivered on the promises and the impact was truly astounding! As quoted by Sir Michael Hirst, IDF President Elect, in the April 2012 issue (vol:57) of the Diabetes Voice; “Dubai’s promotional tagline, ‘The Meeting Place of the World’, rang true when more than 15,000 participants gathered in Dubai for the World Congress, making it the most successful Congress ever organized by the IDF.” Nowlooking ahead, the burden is heavier; the challenge more complex and bigger; and the need to address Diabetes and Endocrine Diseases more urgent. As the Congress President, I have a vision - “To reduce the burden of the disease across our region”. We are united in our stance and the foundation of this vision lies where we left-off in 2009 & 2010, i.e. Education and Knowledge Sharing. These are the corner stones to buildwhat I consider the front-line force to subjugate the disease. So with this as the premise, EDC is reiterating its efforts togather a world class panel of expert speakers, both from international and regional communities, to address a number of key areas and help develop and articulate strategies and protocols that would be beneficial both at the macro and micro level. Ladies and Gentlemen, it gives me immense pleasure to welcome you all once again to the Emirates Diabetes & Endocrine Congress 2012 (; the region’s premier Diabetes and Endocrine education and networking Congress.The event will be held from11 to 13 October, 2012 in Dubai, United Arab Emirates, at the Grand Hyatt Hotel. This year the scientific discourse will be moderated and presented by experts from various scientific backgrounds which will include academic scholars, researchers, physicians and paramedics representing both regional and international perspectives. “Exploring the Shift in the Paradigm of Endocrinology and Diabetes in the Middle East” The 2012-Congress will focus on vital and relevant topics concerning our patients in the region andrunparallel sessions which will include hands-on courses and workshops designed to build capacity. Additionally this year, we are inviting the participants to submit scientific posters to augment the topics (listed below) and the Best 3 Posters chosen by the Scientific Panel will receive awards. Scientific topics discussed at the Congress include: Review of local and International Diabetes Treatment Guidelines Risk Reduction of Cardiovascular Disease in Diabetes Metabolic Consequences of Bariatric Surgery Advances in Incretin Based Therapy Polycystic Ovary Syndrome Gestational Diabetes Mellitus New Insights into the Management of Dyslipidemia Metabolic Consequences of Testosterone Deficiency Long-term Management and Follow up of Thyroid Cancer Metabolic Bone Diseases and Osteoporosis Vitamin-D Deficiency Hyperprolactinemia and Pituitary Tumours Endocrine Hypertension Paediatric Endocrinology The conference will be an excellent opportunity to interact with colleagues from all over the world, share views and create an opportunity for collaboration and building your community of partners. I look forward to meeting you all in Dubai in October 2012, what promises to be the best Scientific Congress on Diabetes and Endocrinology in our region. Thanks and Kind regards,

Dr Abdulrazzaq Ali Al Madani Congress President

Session IV- Obesity

Wednesday, October 10, 2012 08:00-09:00

Registration & Welcome Coffee


Workshop on Thyroid Ultrasound Thursday, October 11, 2012 - Day 1


Metabolic Consequences of Bariatric Surgery Philip Schauer, Cleveland Clinic Bariatric and Metabolic Institute, USA


Recent and Future Drugs for Obesity Luc Van Gaal, Antwerp University Hospital,Belgium


Prayer & Lunch Break

Session V - Cardiovascular Diseases Risk in Diabetes


Registration & Welcome Coffee


Introduction by the Congress Chair Fatheya Al Awadi, Dubai Hospital, UAE Scientific Committee Chairman Iyad Ksseiry, The City Hospital, Dubai, UAE


Early Glycemic Intervention and Long Term Outcomes Alan Garber, Baylor College of Medicine, USA

Session I - The Role of Guidelines in the Management of Diabetes


Targeting Blood Pressure in Diabetic Patients Ryner Dusing, Universitätsklinikum Bonn, Medizinische Universitäts-Poliklinik, Wilhelmstrasse Bonn, Germany

Review of UAE National Diabetes Guidelines Abdulrazzaq Ali Al Madani, Dubai Hospital-DHA, UAE


Diabetic Nephropathy: Is the Kidney the unappreciated heart in type 2 Diabetes? Maximilian Von Eynatten, USA

Review of IDF Guidelines Jean Claude Mbanya, University of Yaoundé I, Cameroon and Consultant Physician, France




Coffee Break

09:30-10:00 10:00-10:30 10:30-11:00

Should Metformin be the First of Therapy in Diabetes? Alan Garber, Baylor College of Medicine, USA


Translating Diabetes Guidelines into Practice Om P. Ghanda, Harvard Medical School, USA




Opening of Exhibition/Lunch Break

Simultaneous MTP sessions


Graduation Ceremony – Postgraduate Certificate in Diabetes - Leicester University Session II -New Therapies for Diabetes Mellitus 13:30-14:00 14:00-14:30

Impact of New Diabetes Therapies: SGLT-2 and Its Inhibitors in Type 2 Diabetes LucVan Gaal, Antwerp University Hospital,Belgium The Role of GLP-1 and GLP-1 Agonists in Type 2 Diabetes Wolfgang Schmidt, Ruhr-University of Bochum School of Medicine, Germany


DPP-4 Inhibitors in Type 2 Diabetes Mark Evans, University of Cambridge, UK


Coffee Break


Individualization of Diabetes Treatment David Richard Mathews, University of Oxford, UK

Replacement with Thyroid Hormone Bernadette Biondi, University of Naples Federico II Medical School Italy

Diabetes Neuropathy and Diabetic Foot Rayaz Malik Central Manchester Foundation Trust & University of Manchester, Core Technology Facility, USA


Registration & Welcome Coffee


Diabetes in Young: Type 1, type 2 or LADA? Rubina Heptulla, Albert Einstein College of Medicine, USA


Gestational Diabetes Mellitus: Diagnosis and Management Donald Coustan, Brown Medical School, USA

Session VI - Hot Topics

Potential for Cardiovascular Benefits of Incretin Based Therapies Om P. Ganda, Harvard Medical School, USA

Diagnosis and Treatment of Testosterone Deficiency Farid Saad, Germany

Friday, October 12, 2012 - Day 2 08:00-09:00

Endocrine Hypertension Ryner Dusing, Universitätsklinikum Bonn, Medizinische Universitäts-Poliklinik, Wilhelmstrasse Bonn, Germany

Saturday, October 13, 2012 - Day 3

Simultaneous MTP Sessions Hyperprolactinemia and Pituitary Tumors Margaret Wierman University of Colorado, School of Medicine USA

Introduction to Pediatric Endocrinology Rubina Heptulla, Albert Einstein College of Medicine, USA

Registration & Welcome Coffee Session III - Emerging Concepts


Advances in Management of Osteoporosis Margaret Wierman, University of Colorado, School of Medicine, USA


Could Testosterone Play a Role in Prevention and Treatment of Type 2 Diabetes in Hypogonadal Men? Farid Saad, Germany


Sulfonylureas: From Molecular Action to Clinical Benefits David Richard Mathews, University of Oxford, UK


Coffee Break

10:30-11:00 11:00-11:45 11:45-12:30 12:30

Coffee Break New Concepts in Diabetes Pathophysiology: What we should know. Ralph Defronzo, University of Texas Health Science Centre and the Audie L. Murphy Memorial VA Hospital, USA Clinical Significance of Subclinical Thyroid Dysfunction. Bernadette Biondi, University of Naples Federico II Medical School, Italy Discussion & Wrap Up Workshops: October 11 & 12, 2012

15:00-16:00 16:00-17:00 15:00-16:00 & 16:00-17:00

Excellence in Diabetes care Diabetes Educators Diabetes Pump *Subject to change

11th & 12th October 2012 11th & 12th October 2012 12th October 2012

Scientific Committee Dr Dr Dr Dr Dr

Fatheya Alawadi, Congress Chair Iyad Ksseiry Chair, Scientific Committee Ahmed Hassoun Ali Baqer Ali Khalil

Dr Dr Dr Dr Dr

Bashar Afandi Hussain Al Saadi Jumaa Al Kaabi Khaled Al Jaberi Salem Arifi Beshyah

EDC 2012 brochure  

EDC 2012 brochure

EDC 2012 brochure  

EDC 2012 brochure